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ABSTRACT It has been suggested that cooperative interactions between antifreeze proteins (AFPs) on the ice surfaces are
required for complete inhibition of ice crystal growth. To test this hypothesis, a 7-kDa type III AFP was linked through its
N-terminus to thioredoxin (12 kDa) or maltose-binding protein (42 kDa). The resultant 20-kDa and 50-kDa fusion proteins were
larger in diameter than free AFP and thus precluded any extensive AFP-AFP contacts on the ice surface. Both fusion proteins
were at least as active as free AFP at virtually all concentrations tested. By these criteria, AFPs function independently of each
other and do not require specific intermolecular interactions to bind tightly to ice.
INTRODUCTION
Antifreeze proteins (AFPs) can protect organisms from
freezing by binding to ice and inhibiting its growth (Davies
and Hew, 1990). This adsorption-inhibition mechanism
(Raymond and DeVries, 1977) operates at the ice surface to
cause a nonequilibrium lowering of the freezing point below
the melting point (thermal hysteresis). Adsorption requires a
specific interaction between the ice-binding site of the AFP
and a structural feature of the ice lattice. Adsorbed AFPs
restrict ice to growing between the bound proteins with a
local surface curvature. The increased surface area and
curvature make it energetically less favorable for water to
join the lattice and results in a local (nonequilibrium) de-
pression of the freezing point (Knight et al., 1991; Wilson,
1993).
It has long been proposed that the basis for adsorption
specificity lies in a hydrogen-bonding match between
groups on the ice-binding site of the AFP and oxygen atoms
on the ice lattice (DeVries and Lin, 1977). For the 37-
amino-acid, -helical type I AFP, seven regularly spaced
Thr and Asx have been postulated to be the principal ice-
binding residues (DeVries and Lin, 1977; Wen and Laursen,
1992a; Sicheri and Yang, 1995) that result in this AFP’s
affinity for the 01–12 direction of the {20–21} pyramidal
plane and their equivalents (Knight et al., 1991), but there is
no general agreement about how the AFP docks to this
surface. There is concern that the number of hydrogen
bonds may be inadequate for the tight binding of mM AFP
in the presence of a 10,000-fold molar excess of water
(Knight et al., 1993; Wen and Laursen, 1992b). Moreover,
x-ray- and NMR-derived structures suggest that the hydro-
gen bond angles and accessibilities on free AFP might not
be optimal for strong binding to ice (Sicheri and Yang,
1995; Gronwald et al., 1996).
Wen and Laursen (1992a) have noted that the relationship
between type I AFP concentration ([AFP]) and the inhibi-
tion of ice growth is biphasic. At low [AFP] ice grows along
both the c and a axes to produce a crystal with a constant
c-to-a axis ratio of 3.3. Above a critical [AFP] (the
threshold concentration), the ice crystal ceases to grow and
thermal hysteresis is observed. Their explanation for these
observations is that AFP binding is reversible at low con-
centrations because the individual interactions between an
AFP and ice are weak. At high concentrations the AFPs
begin to bind cooperatively through side-by-side hydropho-
bic interactions (Wen and Laursen, 1992b). These interpep-
tide interactions are facilitated by alignment of the helices
along the 01–12 direction of the {20–21}pyramidal plane,
which, according to the model of Wen and Laursen (1992b),
brings them into van der Waals contact with each other. In
this way, type I AFP binds to ice as a protein patch where
the total number of hydrogen bonds linking the AFP to the
ice is a multiple of the number of AFPs in the patch.
As a test of this elegant model, Wen and Laursen (1993a)
synthesized type I AFP variants that were designed to
disrupt side-by-side interactions between the helices. One
such variant, in which Ala17 was replaced by Leu, was
completely lacking in thermal hysteresis activity. The bulky
aliphatic side chain was calculated to project at right angles
to the helix surface containing the putative ice-binding
residues and thus sterically interfere with interpeptide inter-
actions. In another test of the model, an all-D-amino acid
enantiomer of type I AFP was synthesized and mixed with
the natural L-amino acid form. Although the two enanti-
omers bound to mirror image directions of the same pyra-
midal plane that would not permit side-by-side packing
(Laursen et al., 1994), they did not interfere with each
other’s activity (Wen and Laursen, 1993b). Nor was there
any sign of interference when three different AFPs (types I,
II, and III) were mixed (Chao et al., 1995), even though
these AFPs are structurally very different (Davies and
Sykes, 1997) and bind to different planes of ice (Cheng and
DeVries, 1991). The latter results are not inconsistant with
the patching hypothesis if each AFP or enantiomer can
self-associate to form a homogeneous patch.
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A similar bimodal relationship between [AFP] and the
inhibition of ice growth has been observed with the 66-
amino-acid, globular type III AFP (DeLuca et al., 1996).
Furthermore, as was observed for type I AFP, high-resolu-
tion x-ray- and NMR-derived structures have suggested that
relatively few hydrogen bonds can be made between the
AFP and ice and that their enthalpic contribution to binding
might be limited by less than optimal bond angles and
lengths (So¨nnichsen et al., 1996; Jia et al., 1996). These
structures have also revealed that the molecule has several
flat, orthogonally related surfaces, one of which is the
putative ice-binding face. These unusual features of the
molecule could theoretically permit side-by-side packing on
the ice surface to form an AFP patch with the ice-binding
sites aligned for binding to the prism planes. To test the
need for cooperativity in type III AFP binding, we have
constructed AFP-fusion proteins with an overall diameter
far exceeding that of the AFP. In this way, the companion
domains would prevent extensive side-by-side interactions
of the AFPs. In effect, the fusion proteins did not suffer any
loss of thermal hysteresis activity. On the contrary, they
were generally more active than the free AFP. These results
are consistent with a model in which AFPs bind indepen-
dently to ice.
MATERIALS AND METHODS
Type III AFP gene modification for cloning into
expression plasmids
DNA constructs were made to attach either maltose-binding protein
(Kellerman and Ferenci, 1982) or thioredoxin (Holmgren, 1985) to the
N-terminus of type III AFP (Fig. 1). To facilitate the cloning, a StuI site
was introduced immediately upstream of the NdeI site that contains the
initiating AUG codon of the synthetic AFP gene (Chao et al., 1993). To aid
purification of the fusion proteins, the gene for type III AFP was extended
to code for six histidines at the C-terminal end of the protein (Janknecht
and Nordheim, 1992). The StuI site and the six histidine codons were added
simultaneously by oligonucleotide-directed mutagenesis (Kunkel et al.,
1987) on single-stranded DNA prepared from the synthetic gene for type
III AFP in vector pT7–7f (DeLuca et al., 1993), using oligonucleotides 1
and 2, respectively, where oligonucleotide 1 had the sequence 5-AA-
GAAGGAGATATAGGCCTCATATGAACCAGG-3, and oligonucleo-
tide 2 had the sequence 5-GGTTACGCTGCTCACCACCACCACCAC-
CACTAAGAATTCGCGC-3. The codons in bold indicate the addition of
two amino acids (Pro-His) to the linker region as a consequence of
introducing the StuI site. Ligated DNA was transformed into competent
Escherichia coli JM 83, and double mutants were recognized by the
presence and absence of StuI and AflII sites, respectively, the latter being
lost during the introduction of the histidine codons. The new plasmid was
designated pT7–7fStuI:AFP:His-tag.
Construction of a thioredoxin fusion plasmid
The thioredoxin fusion vector was prepared by restriction digestion of
pTRXFUS (Invitrogen, San Diego, CA) with NdeI and PstI to release a
0.4-kb fragment containing the entire coding region of thioredoxin and the
in-frame multiple cloning site. The digested plasmid was electrophoresed
on a 1% agarose gel from which the NdeI/PstI fragment was eluted by the
Prep-A-Gene (BioRad, Hercules, CA) method and ligated to NdeI/PstI-
digested pT7–7f. Competent E. coli JM 83 were transformed with the
ligated DNA, and clones were recognized by restriction digestion. The
pT7–7f vector containing the thioredoxin gene was designated pT7–
7fTRX.
The thioredoxin-type III AFP His-tag fusion gene
The pT7–7fStuI:AFP:His-tag plasmid was digested with StuI and ClaI to
release a 0.8-kb fragment, which was recovered as described above and
digested with EcoRI. The StuI/EcoRI fragment containing the AFP:His-tag
DNA was cloned into SmaI/EcoRI-digested pT7–7fTR vector. Clones from
this ligation were designated pT7–7fTRX:AFP:His-tag. Plasmid DNA was
purified from a positive clone and transformed into E. coli BL 21 (DE3)
cells.
Construction of a maltose-binding protein: type
III His-tag fusion gene
The 0.8-kb StuI/ClaI fragment from the pT7–7fStuI:AFP:His-tag plasmid
was prepared as described above and digested with PstI. The StuI/PstI
fragment containing the AFP:His-tag DNA was cloned into XmnI/PstI-
digested pMAL-c2 plasmid (New England Biolabs, Beverley, MA) and
transformed into competent E. coli JM 83. Clones designated as pMal:
AFP:His-tag were detected by restriction digestion, and their plasmid DNA
was transformed into E. coli BL 21 (DE3) cells.
Expression of fusion proteins
LB/amp (100 ml) was inoculated with E. coli BL 21 (DE3) containing
either the pT7–7fTRX:AFP:His-tag or the pMal:AFP:His-tag fusion plas-
mid and incubated at 37°C overnight. The inoculum was added to 4 liters
of LB/amp for growth at 37°C to an OD600 of 0.6, at which point 100
mg/liter of isopropyl--D-thiogalactopyranoside was added, and the culture
was left for an additional 2 h at 37°C. The cells were pelleted by centrif-
ugation for 60 min at 3500  g at 4°C, resuspended in 20 mM Tris-HCl
(pH 8.0), and broken open by sonication. Particulate matter was removed
by centrifugation for 20 min at 12,000  g at 4°C.
FIGURE 1 Ribbon representation of the structures of Type III AFP,
thioredoxin, and maltose-binding protein. The secondary structure was
assigned using STRIDE (Frishman and Argos, 1995), and the representa-
tions were made with MolScript (Kraulis, 1991). The structures are drawn
to the same scale. The amino- and carboxy-termini are labeled N and C,
respectively. The design of the fusion protein took into consideration the
fact that the ice-binding site on type III AFP is located on the opposite side
of the protein from the N-terminus (Chao et al., 1994; So¨nnichsen et al.,
1996; Jia et al., 1996).
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Purification and characterization of
fusion proteins
The supernatant from sonication was loaded onto a 5-ml column of
Ni-nitrilotriacetic acid (NTA) resin (6  1 cm), and the resin was washed
with 25 ml of buffer N (10 mM Tris-HCl, 0.5 M NaCl, 5 mM imidazole)
at pH 8.0 before elution with 100 mM imidazole-HCl (pH 8.0). Fractions
(7 ml) were collected and analyzed by sodium dodecyl sulfate–polyacryl-
amide gel electrophoresis (SDS-PAGE). The thioredoxin fusion protein
was dialyzed against buffer N (3  2 liters) and then rechromatographed
on the Ni-NTA column. No further purification was required.
After one Ni-NTA column chromatography, the partially purified mal-
tose-binding protein was dialyzed against 10 mM Tris-HCl (pH 8.0) (3 
2 liters) and loaded at 2.5 ml/min onto a Q-Sepharose Hi-load (Pharmacia,
Uppsala, Sweden) column that had been preequilibrated with 10 mM
Tris-HCl (pH 8.0). Bound protein was eluted with a linear 0–500 mM
NaCl gradient in 10 mM Tris-HCl (pH 8.0) at a flow rate of 2.5 ml/min.
Fractions (2.5 ml) containing MBP:AFP:His-tag were pooled and concen-
trated by ammonium sulfate precipitation (60%). Precipitated protein was
pelleted by centrifugation at 12,000  g for 20 min. The pellet was
resuspended in a minimum volume of 50 mM Tris-HCl (pH 8.0) and
dialyzed against 50 mM Tris-HCl (pH 8.0) (3  1 liter). The dialysate was
concentrated with a Centricon 10 while the buffer was exchanged for 100
mM NH4CO3. Protein concentrations were routinely estimated by weigh-
ing, by the Bradford assay for protein, or by spectrophotometry. The
concentrations of stock solutions used for antifreeze activity measurements
were determined by amino acid analysis after hydrolysis in 6 N HCl at
160°C for 1.5 h in sealed evacuated tubes. Norleucine was added to the
samples as an internal standard. Hydrolyzed material was analyzed in a
amino acid analyzer (model 6300; Beckman, San Ramon, CA). The masses
of the antifreeze fusion proteins were measured by electrospray mass




Thermal hysteresis, defined as the temperature difference (°C) between the
melting and nonequilibrium freezing points of a solution, was measured
using a nanoliter osmometer (Clifton Technical Physics, Hartford, NY) as
described by Chakrabartty and Hew (1991). All measurements were made
in 100 mM NH4HCO3 (pH 7.9). Ice crystal morphology was observed
through a Leitz dialux 22 microscope and recorded with a Panasonic
CCTV camera linked to a JVC Super VHS video recorder. Still images
were captured with a Silicon Graphics computer and printed on an HP
laserjet 4.
RESULTS AND DISCUSSION
Ice crystal growth as a function of type III
AFP concentration
Ice crystal growth rates were measured at different type III
AFP concentrations by videomicroscopy (Fig. 2). The rela-
tionship between c-axis growth rate and [AFP] was quali-
tatively and quantitatively similar to that obtained by Wen
and Laursen (1992a) for type I AFP. There was no crystal
growth above a threshold concentration of 0.06 mM, and
growth below the threshold value was proportional to
[AFP]. The critical threshold concentration was very close
to that reported for type I AFP, even though the two AFPs
have very different structures.
Type III AFP patching possibilities
If the transition between ice growth and no growth is indeed
due to patch formation, there should be plausible ways in
which the AFPs can self-associate while binding to ice. For
type I AFP, alignment of the single -helix along the
01–12 direction of the {20–21} pyramidal plane appears
to provide an opportunity for interpeptide interactions along
the length of the helix (Wen and Laursen, 1992b). Another
attractive feature of this model is that the stagger of the
helices can be arrranged such that the helix termini are
aligned along the same -1–126 direction as the edge of the
hexagonal bipyramid. Examination of the 3-D structure of
type III AFP (Jia et al., 1996; So¨nnichsen et al., 1996) also
suggests ways in which this protein could form an ice-
binding patch. The relevant structural features are the flat-
ness of the major ice-binding site and the angularity of the
AFP. According to the model for type III AFP binding to
ice, two ranks of hydrogen bonding atoms on the ice-
binding site match oxygen atoms along the 0001 direction
of the {01–01} prism surface. With the AFP bound to ice in
this way, several of its adjoining surfaces are remarkably
flat and almost perpendicular to the ice surface. In a patch-
ing model they might provide enough surface area for
adjacent type III AFPs to bind cooperatively through side-
by-side interactions. Although the antifreeze was modeled
binding to a prism surface and covering the basal plane (Jia
FIGURE 2 Ice crystal growth rates as a function of type III AFP con-
centration. The rate of crystal growth along the c-axis (m/min) at an
undercooling of 0.2°C was measured over a 10-min interval by videomi-
croscopy. Each point represents the average of three determinations.
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et al., 1996), the flexibility of Asn14 would allow the anti-
freeze to bind just to the prism surface (So¨nnichsen et al.,
1996). The possibilities for inter-AFP interactions are also
increased by the fact that the AFP can rotate through 180°
and still bind the 0001 direction of the {01–01} prism
surface. In short, there are too many permutations to prove
or disprove by modeling alone. Therefore, to experimentally
test the cooperative binding hypothesis, it was possible to
take advantage of the robust, compact nature of type III AFP
and the spatial separation of the N- and C-termini from the
ice-binding site to add large fusion moieties (Fig. 1) that
would sterically block specific AFP-AFP interactions with-
out occluding the ice-binding site.
AFP fusion protein isolation
IPTG induction of E. coli bearing the AFP fusion protein
constructs produced prominent protein bands on SDS-
PAGE that were not present in uninduced cells (Fig. 3). The
product from the pTRX:AFP:His-tag plasmid had an appar-
ent Mr of 20,000 on SDS-PAGE and was by far the most
prominent band in the sonicate supernatant. It was substan-
tially purified (Fig. 3) by two cycles of binding and step
elution from the Ni-NTA agarose affinity column (not
shown), with a yield of 5 mg/liter. Its Mr, determined by
electrospray mass spectrometry, was 20,782, which agrees
well with its predicted value (20,880). Its amino acid com-
position (not shown) was consistent with that of the fusion
protein.
The new band appearing after IPTG induction of the
pMal:AFP:His-tag plasmid had an apparent Mr of 50,000
and was of an intensity equivalent to that of several other
proteins in the sonicate supernatant (Fig. 3). This MBP-
AFP-His-tag fusion product was largely purified by a single
cycle of binding and elution from a Ni-NTA agarose affinity
column (not shown). The protein eluted by 0.2 M imidazole
was rechromatographed on a cation exchange column to
remove minor contaminants. After the second chromatog-
raphy, the protein was judged to be pure by SDS-PAGE
(Fig. 3), and its yield was 25 mg/liter. It had aMr of 50,564,
as determined by electrospray mass spectrometry, which is
close to the predicted value of 50,556 for MBP linked to
type III AFP with a His6 extension on the C-terminus. Its
amino acid composition (not shown) was also consistent
with that of the MBP-AFP-His-tag fusion product. Al-
though both AFP fusion proteins have specific affinity
chromatography matrices for their purification (namely
ThioBond (Invitrogen)) for the thioredoxin fusion and an
amylose-agarose composite (NEB) for the MBP fusion, we
found that the C-terminal His-tag provided a more conve-
nient and reliable method of purification.
AFP-fusion proteins show enhanced thermal
hysteresis activity
Concentrated stock solutions of fusion proteins and type III
AFP were prepared in 100 mM NH4HCO3 (pH 7.9) and
clarified by centrifugation. The supernatants were used to
prepare serial dilutions in 100 mM NH4HCO3 (pH 7.9) for
thermal hysteresis measurements over a wide range of con-
centrations from M to mM (Fig. 4, A and B). At low
concentrations, the AFP-fusion proteins were considerably
more active than type III AFP on a molar basis. In the range
0–0.5 mM, the two fusion proteins were up to two or three
times more active at establishing a given degree of thermal
hysteresis than the antifreeze itself (Fig. 4 B). The MBP
fusion protein had limited solubility, and its solution was
close to saturation at 13 mg/ml (0.25 mM). TRX:AFP:His-
tag was soluble up to 180 mg/ml (9 mM), and at this
concentration had a thermal hysteresis activity of 2.0°C
(Fig. 4 A). The most concentrated type III AFP solution
obtained (20 mg/ml or 3 mM) had a thermal hysteresis
reading of 1.4°C. Neither MBP (supplied by B. Shilton,
Biotechnology Research Institute, National Research Coun-
FIGURE 3 SDS-PAGE of fusion protein preparations. (a) TRX:AFP:
His-tag purification. Lane 1, purified thioredoxin (3 g); lane 2, Mr
standards (Bio-Rad); lanes 3 and 4, preinduced and induced BL21 (DE3)
containing pT7–7fTRX:AFP:His-tag, respectively (250 l media); lane
5, purified TRX:AFP fusion protein (3 g). (b) MBP:AFP:His-tag purifi-
cation. Lane 1, purified maltose-binding protein (3 g); lane 2, Mr stan-
dards (Bio-Rad); lanes 3 and 4, preinduced and induced JM 83 containing
pMal:AFP:His-tag, respectively (250 l media); lane 5, purified MBP:
AFP fusion protein (3 g).
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cil of Canada, Montreal, PQ) nor thioredoxin (Invitrogen)
showed any antifreeze activity on their own. MBP (20
mg/ml) and TRX (10 mg/ml) were not only devoid of
thermal hysteresis activity, but they were also unable to
influence the morphology of ice crystals from the uniform
disks obtained in the presence of buffer alone (Fig. 5).
FIGURE 4 Activity profile for wild-type and antifreeze fusion proteins. (a) The thermal hysteresis activities (°C) of MBP:AFP () and TRX:AFP (F)
as a function of concentration are compared to that of the wild-type AFP (‚). Results are the mean  SD of triplicate determinations. (b) Expansion of
a in the sub-mM AFP concentration range.
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Rather than eliminating antifreeze activity, the introduc-
tion of large companion domains made the AFP more active
than the wild-type protein. Despite this change in activity,
the ice crystal morphology obtained with the thioredoxin-
AFP and MBP-AFP fusion proteins was indistinguishable
from that obtained with Type III AFP alone (Fig. 5). It has
previously been noted that the three AFP types (I, II, and
III) produce different ice crystal morphologies (Chao et al.,
1995) that can be attributed to their structural differences
(Davies and Hew, 1990) expressed as a preference for
binding to different planes of ice (Cheng and DeVries,
1991). The formation of a compound ice-binding site with a
contribution from the fusion moiety would be likely to alter
the ice crystal morphology from the typical c:a axis ratio of
2:1. Because this did not happen with either protein, we
conclude that the enhancement of thermal hysteresis does
not result from a change in the ice-binding site. Also in this
regard, because neither MBP nor thioredoxin showed any
antifreeze activity on its own, it can be assumed that the
enhanced activity obtained with the fusion proteins was not
due to the presence of an additional ice-binding site.
Cooperative AFP-AFP interactions are not
required for antifreeze binding to ice
The demonstration that type III AFP fusion proteins are at
least as active as the native protein at almost all concentra-
tions tested up to saturation makes a powerful argument for
this AFP acting independently at the ice surface. What, then,
is the explanation for the biphasic relationship between ice
crystal growth and [AFP]? We suggest that this relationship
is exactly what would be predicted for an AFP binding
independently to ice. At low [AFP] the area between bound
AFPs is large enough for water to join easily to the ice
lattice and overgrow the adsorbed AFP, because the surface
curvature of the individual ice fronts is slight. Even at these
low surface densities, the AFP is bound to a specific plane
(and, in some cases, to a specific direction on the plane).
These are the principles behind ice etching experiments in
which ice hemispheres are grown in dilute AFP solutions
and then allowed to sublime to reveal the AFP-binding
plane/direction (Knight et al., 1991). As the [AFP] in-
creases, the area of the ice fronts between bound AFP
decreases, and the surface curvature needed to overgrow the
bound AFP increases. It is this curvature that is the basis for
the lowering of the nonequilibrium freezing point according
to the Kelvin effect (Wilson, 1993). Our interpretation of
the threshold point in Fig. 2 is that it represents the [AFP]
at which the surface density of adsorbed AFPs is high
enough to ensure that at no point on the ice crystal are AFPs
being overgrown (at that particular degree of undercooling).
In other words, the area between bound AFPs is small
enough to produce adequate curvature on all ice fronts.
Above the threshold point, an increase in [AFP] would only
serve to decrease the probability of growth. Below the
threshold point, the rate at which the ice crystal grows will
be related to the surface density of bound AFP (which itself
is a function of [AFP] and the rate at which AFP binds to
ice).
Concerns that the number and strength of hydrogen bonds
between AFP and ice might be insufficient for tight binding
have driven the patching hypothesis (Wen and Laursen,
1992b) and one other model (Knight et al., 1993) for in-
creasing the number of hydrogen bonds. Recent results from
the 3-D structural analysis of type III AFP (So¨nnichsen et
al., 1996; Jia et al., 1996) and from type I AFP structure-
function analysis (Chao et al., 1997) support the notion that
hydrogen bonding alone is perhaps inadequate, but suggest
that significant contributions to the energetics of binding
may come from van der Waals interactions and entropic
solvation effects resulting from the fit of AFP to ice.
Increased activity of AFP-fusion proteins
The Kelvin effect can also be invoked to explain the en-
hanced activity of the AFP-fusion proteins. We suggest that
the AFP fusion proteins are more active, either because each
molecule covers more of the ice surface, and/or because it is
harder for the ice to grow over them. Again, this is consis-
tent with the model proposed by Wilson (1993) relating
freezing point depression to average adsorbant spacing and
ice surface distortion. Fig. 6 shows this scenario in diagram-
matical form, where the larger fusion protein binding to the
ice with the same affinity and surface density would require
the ice in between to grow with a more pronounced surface
curvature. In the adsorption-inhibition model of macromo-
lecular antifreeze action (Raymond and DeVries, 1977), the
lowering of the nonequilibrium freezing point by AFPs is
due to the increased energetic costs of adding water to a
convex ice surface. Thus an antifreeze that increases ice
curvature at the same molar concentration of AFP translates
into a more powerful antifreeze.
FIGURE 5 Photomicrographs of ice crystals. Ice crystals were formed in
the presence and absence of AFP-fusion proteins and their constituents. Ice
crystal (a) in the absence of protein; (b) in the presence of thioredoxin (10
mg/ml) in 100 mM NH4HCO3 (pH 7.9); (c) in the presence of maltose-
binding protein (20 mg/ml) in 100 mM NH4HCO3 (pH 7.9). Photographs
were taken at 0.02°C of undercooling. The right-hand panel shows ice
crystals formed in the presence of 100 mM NH4HCO3 (pH 7.9) and mM
concentrations of (d) wild-type AFP, (e) TRX:AFP, and (f) MBP:AFP at
0.2°C undercooling.
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Applications for AFP fusion proteins
This work on recombinant AFP fusion proteins contributes
to the antifreeze field in two areas. In terms of antifreeze
function, it demonstrates that AFPs can function indepen-
dently at the ice surface, and that cooperativity is not needed
for antifreeze activity. It also provides a protein engineering
approach to increasing the activity of type III AFP and, by
inference, the activity of other AFPs that tolerate N- or
C-terminal extensions without occluding the ice-binding
site. Thus lower concentrations of AFP fusions can be
employed to give the same degree of thermal hysteresis and
perhaps inhibition of ice recrystallization. Because the na-
ture of the fusion moiety does not seem to be that important,
it could be chosen to facilitate high yields in an expression
system or to provide a streamlined purification protocol
without the need for subsequent proteolytic removal of the
fusion domain. The AFP fusion approach may provide
significant advantages in transgenic systems. The addition
of large, stable proteins to AFPs may slow their clearance
by excretion or degradation. Moreover, fusion of the AFP to
selected proteins in the host system may impart localization,
tissue and stage specificity, or other beneficial properties
deriving from the association with a particular protein. Not
only can the fusion increase the activity of Type III AFP; it
may also add new functions to the protein.
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